Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders

Details

• Alternative Title:
  Vaccine
• Personal Author:
  McClure, David L. ; Jacobsen, Steven J. ; Klein, Nicola P. ; Naleway, Allison L. ; Kharbanda, Elyse O. ; Glanz, Jason M. ; Jackson, Lisa A. ; Weintraub, Eric S. ; McLean, Huong Q.
• Description:
  Background:
  
  Febrile seizures are associated with the first dose of measles-containing vaccines and the risk increases with chronologic age during the second year of life. We used the Vaccine Safety Datalink (VSD) to determine if the relative increase in risk of seizures following receipt of measles-containing vaccine differs by gestational age at birth.
  
  Methods:
  
  Children were eligible if they received their first dose of measles-containing vaccine at age 12 through 23 months from January 2003 through September 2015. Children were excluded if they had a history of seizure or conditions strongly related to seizure prior to 12 months of age. Seizures were identified by diagnostic codes in the inpatient or emergency department settings. Using risk-interval analysis, we estimated the incidence rate ratio (IRR) for seizures in the 7 through 10 days (risk period) vs 15 through 42 days (control period) following receipt of measles-containing vaccines in children born preterm (<37 weeks gestation age) and those born full-term (≤37 weeks).
  
  Results:
  
  There were 532,375 children (45,343 preterm and 487,032 full-term) who received their first dose of measles-containing vaccine at age 12 through 23 months. The IRRs of febrile seizures 7 through 10 days compared with 15 through 42 days after receipt of measles-containing vaccine were 3.9 (95% CI: 2.5–6.0) in preterm children and 3.2 (2.7–3.7) in full-term children; the ratio of IRRs: was 1.2 (0.76–1.9), p = 0.41. IRRs were also similar across gestational age groups, by vaccine type received (measles-mumps-rubella [MMR] or measles-mumps-rubella-varicella [MMRV]) and age at vaccination (12–15 or 16–23 months).
  
  Conclusion:
  
  Vaccination with a measles-containing vaccine in the second year of life is associated with a similar relative risk of a first seizure in children born preterm as in those who were born full-term.
  
  
• Subjects:
  Chickenpox Vaccine Female Gestational Age Humans Infant Infant, Premature Male Measles Measles-Mumps-Rubella Vaccine Risk Assessment Seizures, Febrile Term Birth United States Vaccination Vaccines, Combined

  More +
• Keywords:
  Measles Containing Vaccine MMR MMRV Premature Preterm Seizures
• Source:
  Vaccine. 37(1):76-79
• Pubmed ID:
  30478005
• Pubmed Central ID:
  PMC6530777
• Document Type:
  Journal Article
• Funding:
  CC999999/Intramural CDC HHSUnited States/
• Volume:
  37
• Issue:
  1
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:a339941f3be50a1e562e4441f51ac5b5c7c1e81f6bbda53d43a92c89f4b504fc04da7d3f2b5950d478df2b83c10098cced96c552d7da41da7d8ea8a294d2d5c2
• Download URL:
  https://stacks.cdc.gov/view/cdc/79003/cdc_79003_DS1.pdf
• File Type:
  [PDF - 66.24 KB ]